US$ 27.16
bpc 157 human clinical trial gastric ulcer Stable Pentadecapeptide as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System BPC-157 Peptide Therapy | Regenerative
Description
It is the standard diluent used to reconstitute lyophilised research peptides because it tolerates multiple stopper punctures across a 28-day in-use period

Raising the KLOW dose to compensate would also raise GHK-Cu excessively

Even some over-the-counter vitamins can be a cause, as vitamin B-12 can result in a fluorescent yellow or green tint

This drug has an extremely low addiction and dependency potential, therefore classifying it as a Schedule IV drug here in Nashville
